A multimodular heterotrimeric complex encompassing a trimodular C-terminal fragment of the cellulosomal scaffoldin CipA from C. thermocellum bound to the type II cohesin module of SdbA and the type I dockerin module of CelD has been crystallized by the hanging-drop vapour-diffusion method and initial X-ray diffraction data analysis has been conducted.
Keywords: cellulosome, cohesins, dockerins
Abstract
The multimodular scaffoldin subunit CipA is the central component of the cellulosome, a multienzyme plant cell-wall-degrading complex, from Clostridium thermocellum. It captures secreted cellulases and hemicellulases and anchors the entire complex to the cell surface via high-affinity calcium-dependent interactions between cohesin and dockerin modules termed type I and type II interactions. The crystallization of a heterotrimeric complex comprising the type II cohesin module from the cell-surface protein SdbA, a trimodular C-terminal fragment of the scaffoldin CipA and the type I dockerin module from the CelD cellulase is reported. The crystals belonged to space group P212121, with unit-cell parameters a = 119.37, b = 186.31, c = 191.17 Å. The crystals diffracted to 2.7 Å resolution with four or eight molecules of the ternary protein complex in the asymmetric unit.
1. Introduction
The cellulosome is a large cell-surface-bound multienzyme complex that is responsible for the degradation of cellulose and other plant cell-wall polysaccharides. Originally discovered in the thermophilic anaerobe Clostridium thermocellum (Lamed, Kenig et al., 1983 ▶; Lamed, Setter et al., 1983 ▶), cellulosomes have since been identified in a variety of other anaerobic bacteria, ruminal bacteria and anaerobic fungi (for reviews, see Bayer et al., 1998 ▶, 2004 ▶; Beguin & Lemaire, 1996 ▶; Doi & Kosugi, 2004 ▶; Schwarz, 2001 ▶). The cellulosome of C. thermocellum is composed of three modular protein components: cellulases, hemicellulases and other hydrolytic enzymes, the CipA scaffoldin subunit (Gerngross et al., 1993 ▶) and one of three cell-surface-associated proteins (SdbA, OlpB or Orf2p; Leibovitz & Beguin, 1996 ▶; Leibovitz et al., 1997 ▶; Lemaire et al., 1995 ▶; Fig. 1 ▶). Cellulosome assembly is mediated by two types of high-affinity calcium-dependent interactions between cohesin (Coh) and dockerin (Doc) modules. The type I interaction is responsible for localizing the various enzymes to the scaffoldin, while the type II interaction anchors the scaffoldin to a cell-surface-associated protein. The CipA scaffoldin contains nine type I Coh modules, a type II Doc module, an X-module of unknown function and a cellulose-specific carbohydrate-binding module (CBM), all of which are connected by flexible linkers of varying length (Fig. 1 ▶).
In order to obtain a better structural understanding of the scaffoldin, crystal structures have been obtained for the individual type I and type II Coh and Doc modules (Lytle et al., 2001 ▶; Shimon et al., 1997 ▶; Tavares et al., 1997 ▶) and their complexes (Adams et al., 2006 ▶; Carvalho et al., 2003 ▶, 2007 ▶), the CBM (Tormo et al., 1996 ▶) and the X-module (Adams et al., 2006 ▶). However, few multimodular structures have been determined, which is likely to be a consequence of the inherent flexibility of the linker regions that separate each module. Here, we report the generation, purification, crystallization and preliminary X-ray characterization of a heterotrimeric multimodular complex including the three C-terminal modules of CipA (residues 1533–1853) bound to the type I Doc module (DocI) from the CelD cellulase (residues 549–625) and the type II Coh (CohII) module from the cell-surface protein SdbA (residues 27–200).
2. Expression, purification and complex formation
The C-terminal CohI9-X-DocII fragment of CipA with a C-terminal hexahistidine tag, SdbA CohII with an N-terminal hexahistidine tag and CelD DocI with an N-terminal dodecahistidine tag were all recombinantly expressed and purified in a similar manner. Briefly, transformed BL21 (DE3) cells (Novagen) were grown in LB medium supplemented with 100 mg l−1 ampicillin at 310 K while shaking until an OD600 of 0.6 was reached. IPTG was added to a final concentration of 1 mM and growth was continued for an additional 4 h. The cells were harvested by centrifugation (20 min at 3000g), resuspended in 20 ml buffer A (25 mM Tris–HCl pH 7.4, 250 mM NaCl, 8 M urea) and lysed by sonication on ice. The insoluble fraction was removed by centrifugation at 20 000g in a Beckman JA-20 rotor for 20 min. The supernatant was applied onto an Ni2+-charged chelating column pre-equilibrated in buffer A. The column was subsequently washed with buffer A containing 20 mM imidazole and the bound protein was eluted with buffer A containing 400 mM imidazole. Purified CohI9-X-DocII, DocI and CohII were pooled and refolded by dialysis into buffer B (20 mM HEPES pH 7.5, 50 mM NaCl, 1 mM CaCl2 and 1 mM DTT). The refolded complex was separated from excess unbound proteins by size-exclusion chromatography using a HiLoad 16/60 Superdex 200 size-exclusion column (Amersham Pharmacia Biosciences) equilibrated in buffer B. The protein was eluted in 4 ml fractions using buffer B and its purity was confirmed via SDS–PAGE with Coomassie Blue staining (Fig. 2 ▶).
3. Crystallization
The DocI–CohI9-X-DocII–CohII complex crystals were grown by hanging-drop vapour diffusion with a drop containing 2 µl protein at 28 mg ml−1 and 2–4 µl reservoir solution consisting of 100 mM HEPES pH 7–7.75, 1.3–1.5 M lithium sulfate and 0.5 µl 1 M potassium sodium tartrate. The crystals took 7–10 d to grow at room temperature. The crystals were tetragonal in shape, with dimensions of 0.25 × 0.25 × 0.20 mm (Fig. 3 ▶).
4. Data collection and processing
X-ray data were collected on beamline 9-2 at the Stanford Synchrotron Radiation Lightsource (SSRL) using a MarMosaic 325 CCD detector (MAR USA). Data were collected at 100 K from crystals that had been soaked in reservoir solution containing 20% glycerol as a cryoprotectant and flash-frozen in liquid nitrogen.
The crystals belonged to the primitive orthorhombic space group P212121, with unit-cell parameters a = 119.37, b = 186.31, c = 191.17 Å. Matthews coefficients of 4.08 and 2.04 Å3 Da−1 were obtained with solvent contents of 69.85% and 39.70% for an asymmetric unit containing four and eight heterotrimeric protein complexes, respectively. The data were processed to 2.7 Å resolution with an R merge of 4.6% (Table 1 ▶) using HKL-2000 (Otwinowski & Minor, 1997 ▶). A molecular-replacement strategy based on the X-Doc–CohII structure (Adams et al., 2006 ▶) and the CohI–DocI structures (Carvalho et al., 2003 ▶, 2007 ▶) is being employed to solve the structure of the DocI–CohI9-X-DocII–CohII heterotrimeric complex.
Table 1. Diffraction data statistics for native DocI–CohI9-X-DocII–CohII complex crystals.
Space group | P212121 |
Unit-cell parameters (Å) | a = 119.37, b = 186.31, c = 191.17 |
Wavelength (Å) | 0.97927 |
Temperature (K) | 100 |
Resolution range (Å) | 30.0–2.7 (2.8–2.7) |
Observed reflections | 113244 |
Unique reflections | 107440 |
Data completeness (%) | 95.8 (78.5) |
Redundancy | 3.6 (2.4) |
Rmerge† (%) | 4.6 (75.5) |
〈I/σ(I)〉 | 30.9 (1.9) |
Matthews coefficient (Å3 Da−1) | 4.08/2.04‡ |
Solvent content (%) | 69.85 |
R merge = , where Ii(hkl) and 〈I(hkl)〉 represent the diffraction-intensity values of the individual measurements and the corresponding mean values.
Four/eight heterotrimeric protein complexes per asymmetric unit.
Acknowledgments
We would like to acknowledge SSRL for synchrotron data collection. ZJ is a Canada Research Chair in Structural Biology. SPS is a Canadian Institutes of Health Research New Investigator. This research was supported by a Canadian Institutes of Health Research Operating Grant (ZJ) and a National Science and Engineering Research Council of Canada Discovery Grant (SPS).
References
- Adams, J. J., Pal, G., Jia, Z. & Smith, S. P. (2006). Proc. Natl Acad. Sci. USA, 103, 305–310. [DOI] [PMC free article] [PubMed]
- Bayer, E. A., Belaich, J. P., Shoham, Y. & Lamed, R. (2004). Annu. Rev. Microbiol.58, 521–554. [DOI] [PubMed]
- Bayer, E. A., Chanzy, H., Lamed, R. & Shoham, Y. (1998). Curr. Opin. Struct. Biol.8, 548–557. [DOI] [PubMed]
- Beguin, P. & Lemaire, M. (1996). Crit. Rev. Biochem. Mol. Biol.31, 201–236. [DOI] [PubMed]
- Carvalho, A. L., Dias, F. M., Nagy, T., Prates, J. A., Proctor, M. R., Smith, N., Bayer, E. A., Davies, G. J., Ferreira, L. M., Romão, M. J., Fontes, C. M. & Gilbert, H. J. (2007). Proc. Natl Acad. Sci. USA, 104, 3089–3094. [DOI] [PMC free article] [PubMed]
- Carvalho, A. L., Dias, F. M., Prates, J. A., Nagy, T., Gilbert, H. J., Davies, G. J., Ferreira, L. M., Romão, M. J. & Fontes, C. M. (2003). Proc. Natl Acad. Sci. USA, 100, 13809–13814. [DOI] [PMC free article] [PubMed]
- Doi, R. H. & Kosugi, A. (2004). Nature Rev. Microbiol.2, 541–551. [DOI] [PubMed]
- Gerngross, U. T., Romaniec, M. P., Kobayashi, T., Huskisson, N. S. & Demain, A. L. (1993). Mol. Microbiol.8, 325–334. [DOI] [PubMed]
- Lamed, R., Kenig, R., Setter, E. & Bayer, E. A. (1983). Biotechnol. Bioeng. Symp.13, 163–181.
- Lamed, R., Setter, E. & Bayer, E. A. (1983). J. Bacteriol.156, 828–836. [DOI] [PMC free article] [PubMed]
- Leibovitz, E. & Beguin, P. (1996). J. Bacteriol.178, 3077–3084. [DOI] [PMC free article] [PubMed]
- Leibovitz, E., Ohayon, H., Gounon, P. & Beguin, P. (1997). J. Bacteriol.179, 2519–2523. [DOI] [PMC free article] [PubMed]
- Lemaire, M., Ohayon, H., Gounon, P., Fujino, T. & Beguin, P. (1995). J. Bacteriol.177, 2451–2459. [DOI] [PMC free article] [PubMed]
- Lytle, B. L., Volkman, B. F., Westler, W. M., Heckman, M. P. & Wu, J. H. (2001). J. Mol. Biol.307, 745–753. [DOI] [PubMed]
- Otwinowski, Z. & Minor, W. (1997). Methods Enzymol.276, 307–326. [DOI] [PubMed]
- Schwarz, W. H. (2001). Appl. Microbiol. Biotechnol.56, 634–649. [DOI] [PubMed]
- Shimon, L. J., Bayer, E. A., Morag, E., Lamed, R., Shoham, Y. & Frolow, F. (1997). Structure, 3, 381–390. [DOI] [PubMed]
- Tavares, G. A., Beguin, P. & Alzari, P. M. (1997). J. Mol. Biol.273, 701–713. [DOI] [PubMed]
- Tormo, J., Lamed, R., Chirino, A. J., Morag, E., Bayer, E. A., Shoham, Y. & Steitz, T. A. (1996). EMBO J.15, 5739–5751. [PMC free article] [PubMed]